Clinical Significance of Residual Lymph Node Metastasis in Predicting Recurrence After Preoperative Chemotherapy and Surgery for Gastric Cancer
Anticancer Research · 2025
DOI: 10.21873/anticanres.17507 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Keisuke Komori und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan. Hauptthemen laut MEDLINE: Stomach Neoplasms, Gastrectomy, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND/AIM: Neoadjuvant chemotherapy is gaining recognition for its potential to improve survival outcomes, with combined neoadjuvant and adjuvant therapies under investigation. However, the prognostic significance of post-chemotherapy pathological staging (ypStage) on recurrence-free survival (RFS) remains unclear. This study aimed to evaluate the utility of ypStage, ypT, ypN classification, and histological response rate in predicting recurrence after gastrectomy. PATIENTS AND METHODS: This retrospective study included 125 patients who underwent radical gastrectomy after preoperative chemotherapy at the Kanagawa Cancer Center between January 2007 and November 2019. RFS was analyzed based on ypStage, ypT, ypN classification, and histological response rate, with prognostic factors also assessed. RESULTS: The 5-year RFS rates were 81.6% for ypStage I, 49.0% for ypStage II, and 42.9% for ypStage III. Significant differences were observed between ypStage I and ypStage II (p=0.025) but not between ypStage II and ypStage III (p =0.633). In ypStage II/III cases, the 5-year RFS rate was significantly higher for ypN0/1/2 (55.4%) compared to ypN3 (21.5%) (p=0.003). ypN was selected as an independent predictor for relapse in multivariate analysis. CONCLUSION: ypStage effectively predicts recurrence in ypStage I cases after preoperative chemotherapy and surgery for gastric cancer. However, prognosis in patients with ypStage II/III is better stratified using the ypN classification, particularly ypN3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
- Department of Surgery, International University of Health and Welfare, Atami, Japan.
- Department of Surgery, Yokohama City University, Yokohama, Japan.
- Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan; takay0218@yahoo.co.jp.
- Department of Information Sciences, Tokyo University of Science, Tokyo, Japan.
Zitieren
APA
Komori, K., Yamada, T., Ando, S., Nagasawa, S., Kanematsu, K., Morita, J., Tanabe, M., Nakayama, Y., Rino, Y., Saito, A., Ogata, T., & Oshima, T. (2025). Clinical Significance of Residual Lymph Node Metastasis in Predicting Recurrence After Preoperative Chemotherapy and Surgery for Gastric Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17507
Vancouver
Komori K, Yamada T, Ando S, Nagasawa S, Kanematsu K, Morita J, et al. Clinical Significance of Residual Lymph Node Metastasis in Predicting Recurrence After Preoperative Chemotherapy and Surgery for Gastric Cancer. Anticancer Research. 2025. doi:10.21873/anticanres.17507
BibTeX
@article{Komori2025,
author = {Komori, Keisuke and Yamada, Takanobu and Ando, Shuji and Nagasawa, Shinsuke and Kanematsu, Kyohei and Morita, Junya and Tanabe, Mie and Nakayama, Yuta and Rino, Yasushi and Saito, Aya and Ogata, Takashi and Oshima, Takashi},
title = {Clinical Significance of Residual Lymph Node Metastasis in Predicting Recurrence After Preoperative Chemotherapy and Surgery for Gastric Cancer},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17507}
}
EUVIMED